Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain

Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain

This study analysed the role of several risk factors for hospitalization due to community-acquired, respiratory syncytial virus (RSV) infection. The risk factors detected in infants hospitalized for RSV infection in the first 24 months of life were compared with those in the general infant populatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Epidemiology and infection 2006-06, Vol.134 (3), p.506-513
Hauptverfasser: CILLA, G., SARASUA, A., MONTES, M., AROSTEGUI, N., VICENTE, D., PÉREZ-YARZA, E., PÉREZ-TRALLERO, E.
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Biological and medical sciences
Birth weight
Cardiovascular disease
Children
Congenital diseases
Congenital heart defects
Disease prevention
Fundamental and applied biological sciences. Psychology
Gestational age
Heart
Heart Defects, Congenital - complications
Hospitalization
Hospitalization - statistics & numerical data
Human respiratory syncytial virus
Humans
Infant
Infant, Low Birth Weight
Infant, Newborn
Infants
Infections
Low birth weight
Lung diseases
Maternal Age
Microbiology
Multivariate Analysis
Palivizumab
Population
Predisposing factors
Premature Birth
Questionnaires
Respiratory syncytial virus
Respiratory syncytial virus infections
Respiratory Syncytial Virus Infections - complications
Respiratory Syncytial Virus Infections - prevention & control
Retrospective Studies
Risk Factors
Siblings
Spain
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study analysed the role of several risk factors for hospitalization due to community-acquired, respiratory syncytial virus (RSV) infection. The risk factors detected in infants hospitalized for RSV infection in the first 24 months of life were compared with those in the general infant population in our region. There were 361 episodes of hospitalization in 357 infants. Eighty per cent of the infants did not present underlying conditions for severe RSV infection and only 10 (3%) were candidates for palivizumab prophylaxis. In multivariate analysis, birthweight of
ISSN:0950-2688
1469-4409
DOI:10.1017/S0950268805005571